ANTI-ADIPOCYTE FATTY ACID-BINDING PROTEIN (AP2), ANTI-FLAP AND ANTI-CYSLT1 RECEPTOR HERBAL COMPOSITIONS
    14.
    发明申请
    ANTI-ADIPOCYTE FATTY ACID-BINDING PROTEIN (AP2), ANTI-FLAP AND ANTI-CYSLT1 RECEPTOR HERBAL COMPOSITIONS 有权
    抗-ADIPOCOCTETE脂肪酸结合蛋白(AP2),抗逆转录病毒和抗CYSLT1受体草药组合物

    公开(公告)号:US20090298941A1

    公开(公告)日:2009-12-03

    申请号:US12477643

    申请日:2009-06-03

    IPC分类号: A61K31/19 A61P3/04

    摘要: Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of Boswellia serrata. More particularly, these herbal compositions comprise an effective amount of an enriched Boswellia extract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-β-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of Aegle marmelos, an extract of Zingiber officinale, an extract of Garcinia mangostana, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.

    摘要翻译: 具有抗脂肪细胞脂肪酸结合蛋白(aP2),抗5-脂氧合酶活化蛋白(FLAP)和抗半胱氨酰白三烯(CysLT)-1受体表达活性的草药组合物含有乳香乳杆菌的提取物。 更具体地说,这些草药组合物包含有效量的含有10%至99%(重量)3-0-乙酰基-11-酮-β-乳糖酸的富集乳香提取物; 和有效量的选自Aegle marmelos的提取物,Zingiber officinale的提取物,Garcinia mangostana的提取物及其混合物的第二提取物。 这些可以用于饮食补充剂或药物制剂中,用于控制与炎症相关或与炎症有关的疾病。 这些疾病特别包括呼吸系统疾病如哮喘,过敏性鼻炎,花粉症,1型超敏反应和轻度过敏。 组合物也可用于皮肤护理。